The article names gastroparesis, a history of pancreatitis, renal impairment, and severe dehydration as conditions requiring careful evaluation before initiation
There may be a brief gap in appetite suppression as you begin at the lower retatrutide dose, which is temporary
6 Therefore, the general ASA recommendations may not be consistent with the pharmacokinetics in special cases, as these recommendations fail to differentiate between patients taking a GLP-1RA for diabetes or weight loss
Researchers investigate intranasal delivery as an experimental route for studying peptide transport, formulation science, and pharmaceutical delivery technologies
Taking a GLP-1 medication can change your eating habits and diet, and supporting your nutrient intake with a dietary supplement can be a convenient way to help bridge possible nutrient gaps that may arise from these changes